Biotech

All Articles

Daiichi pays Merck $170M to develop lung cancer cells T-cell engager treaty

.Merck &amp Co. has actually swiftly recouped several of the costs of its own Harp on Therapies purc...

BioMarin halts preclinical gene treatment for heart disease

.After BioMarin carried out a spring season tidy of its own pipe in April, the firm has actually det...

Eisai vegetations molecular glue SEED along with $1.5 B biobucks work

.Big Pharmas remain caught to the tip of molecular adhesive degraders. The latest business to observ...

Life scientific research credit report organization unveils with $600M

.A new worldwide lifestyle scientific research debt company, called Symbiotic Capital, has raised mu...

BMS channels TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is actually axing another major wager coming from the Caforio age, terminating...

Nuvation stops wager inhibitor after taking into consideration phase 1 information

.After having a look at stage 1 data, Nuvation Bio has made a decision to stop work with its one-tim...

' Scientific intuitiveness' led FDA consultants to back Zevra's rare illness med

.Zevra Therapies' uncommon health condition drug seems to be on the pathway to permission this fall ...

Pfizer takes $230M hit after axing stopped working DMD genetics treatment

.Pfizer's period 3 Duchenne muscle dystrophy (DMD) genetics therapy failing has gone a $230 million ...

AC Immune sees 'spots' possible in Alzheimer's medicine data

.After more than twenty years of deal with neurodegenerative diseases, Swiss biotech a/c Immune syst...

GSK loses ph. 2 HPV injection over absence of best-in-class possible

.GSK has junked a phase 2 human papillomavirus (HPV) vaccine coming from its own pipe after making a...